Subscribe To
ELEV / Why Is Elevation Oncology (ELEV) Stock Down 26% Today?
ELEV News
By InvestorPlace
June 9, 2023
Why Is Elevation Oncology (ELEV) Stock Down 26% Today?
Elevation Oncology (NASDAQ: ELEV ) stock is taking a beating on Friday after the healthcare company announced a public stock offering. That public of more_horizontal
By MarketBeat
May 30, 2023
Steve Cohen's Point72 Disclosed 8.7% Stake In Elevation Oncology
Elevation Oncology NASDAQ: ELEV is a biotech company that focuses on discovering and developing cancer therapies. The company aims to treat patients w more_horizontal
By InvestorPlace
May 26, 2023
Why Is Elevation Oncology (ELEV) Stock Up 57% Today?
Elevation Oncology (NASDAQ: ELEV ) stock is on the rise Friday despite a lack of news from the pharmaceutical company. There's no news that explains w more_horizontal
By Zacks Investment Research
March 23, 2023
Are Medical Stocks Lagging Elevation Oncology (ELEV) This Year?
Here is how Elevation Oncology, Inc. (ELEV) and Senesco Technologies Inc. (ELOX) have performed compared to their sector so far this year. more_horizontal
By PRNewsWire
May 26, 2022
Elevation Oncology to Present Initial Seribantumab Proof-of-Concept Data from Phase 2 CRESTONE Study in Patients with Tumors Harboring NRG1 Fusions at ASCO 2022
Positive initial data support the potential of seribantumab to induce deep and durable benefit for patients with tumors harboring NRG1 fusions Clinica more_horizontal